# Randomized Controlled Trial of Surfactant Administration by Laryngeal Mask Airway (LMA)

> **NCT00599651** · NA · TERMINATED · sponsor: **University of Virginia** · enrollment: 380 (estimated)

## Conditions studied

- Respiratory Distress Syndrome, Newborn

## Interventions

- **DEVICE:** Surfactant administered via Laryngeal Mask Airway (LMA)
- **OTHER:** standard of care (nasal CPAP and supplemental oxygen)

## Key facts

- **NCT ID:** NCT00599651
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-06
- **Primary completion:** 2009-06
- **Final completion:** 2009-12
- **Target enrollment:** 380 (ESTIMATED)
- **Why stopped:** Study was closed due to extremely low enrollment
- **Last updated:** 2010-05-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00599651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00599651, "Randomized Controlled Trial of Surfactant Administration by Laryngeal Mask Airway (LMA)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00599651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*